Different pattern of epigenetic changes of the GNAS gene locus in patients with pseudohypoparathyroidism type Ic confirm the heterogeneity of underlying pathomechanisms in this subgroup of pseudohypoparathyroidism and the demand for a new classification of GNAS-related disorders

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 8, 2014, Pages

  Brix, Bettina ^a   Werner, Ralf ^a   Staedt, Pia ^a   Struve, Dagmar ^a   Hiort, Olaf ^a   Thiele, Susanne ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DNA METHYLATION; DNA MUTATIONAL ANALYSIS; EPIGENESIS, GENETIC; FEMALE; GENETIC HETEROGENEITY; GENETIC LOCI; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PSEUDOHYPOPARATHYROIDISM;

EID: 84905833739     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-4477     Document Type: Article

References (40)

1. Bastepe M. The GNAS locus and pseudohypoparathyroidism. Adv Exp Med Biol. 2008;626:27-40.
2. Elli FM, deSanctis L, Ceoloni B, et al. Pseudohypoparathyroidism type Ia and pseudo-pseudohypoparathyroidism: the growing spectrum of GNAS inactivating mutations. Hum Mutat. 2013;34:411-416.
3. LevineMA, DownsRWJr, Singer M, Marx SJ, Aurbach GD, Spiegel AM. Deficient activity of guanine nucleotide regulatory protein in erythrocytes from patients with pseudohypoparathyroidism. Biochem Biophys Res Commun. 1980;94:1319-1324.
4. Levine MA, Ahn TG, Klupt SF, et al. Genetic deficiency of the β subunit of the guanine nucleotide-binding protein Gs as the molecular basis for Albright hereditary osteodystrophy. Proc Natl Acad Sci USA. 1988;85:617-621.
5. Freson K, Izzi B, Labarque V, et al. GNAS defects identified by stimulatoryGproteinα-subunit signalling studies in platelets. J Clin Endocrinol Metab. 2008;93:4851-4859.
6. Linglart A, Bastepe M, Jüppner H. Similar clinical and laboratory findings in patients with symptomatic autosomal dominant and sporadic pseudohypoparathyroidism type Ib despite different epigenetic changes at the GNAS locus. Clin Endocrinol (Oxf). 2007;67:822-831.
7. Linglart A, Gensure RC, Olney RC, Jüppner H, Bastepe M. A novel STX16deletion in autosomal dominant pseudohypoparathyroidism type Ib redefines the boundaries of a cis-acting imprinting control element of GNAS. Am J Hum Genet. 2005;76:804-814.
8. Bastepe M, Fröhlich LF, Hendy GN, et al. Autosomal dominant pseudohypoparathyroidism type Ib is associated with a heterozygous microdeletion that likely disrupts a putative imprinting control element of GNAS. J Clin Invest. 2003;112:1255-1263.
9. Bastepe M, Fröhlich LF, Linglart A, et al. Deletion of the NESP55 differentially methylated region causes loss of maternal GNAS imprints and pseudohypoparathyroidism type Ib. Nat Genet. 2005; 37:25-27.
10. Chillambhi S, Turan S, Hwang DY, Chen HC, Jüppner H, Bastepe M. Deletion of the noncoding GNAS antisense transcript causes pseudohypoparathyroidism type Ib and biparental defects of GNAS methylation in cis. J Clin Endocrinol Metab. 2010;95:3993-4002.
11. Richard N, Abeguilé G, Coudray N, et al. A new deletion ablating NESP55 causes loss of maternal imprint of A/B GNAS and autosomal dominant pseudohypoparathyroidism type Ib. J Clin Endocrinol Metab. 2012;97:E863-E867.
12. Bastepe M, Altug-Teber O, Agarwal C, Oberfield SE, Bonin M, Jüppner H. Paternal uniparental isodisomy of the entire chromosome 20 as a molecular cause of pseudohypoparathyroidism type Ib (PHP-Ib). Bone. 2011;48:659-662.
13. Bastepe M, Lane AH, Jüppner H. Paternal uniparental isodisomy of chromosome20q-and the resulting changes inGNAS1methylation-as a plausible cause of pseudohypoparathyroidism. Am J Hum Genet. 2001;68:1283-1289.
14. Dixit A, Chandler KE, Lever M, et al. Pseudohypoparathyroidism type 1b due to paternal uniparental disomy of chromosome 20q. J Clin Endocrinol Metab. 2013;98:E103-E108.
15. Fernández-Rebollo E, Lecumberri B, Garin I, et al.Newmechanisms involved in paternal 20q disomy associated with pseudohypoparathyroidism. Eur J Endocrinol. 2010;163:953-962.
16. Weinstein LS. Albright hereditary osteodystrophy, pseudohypoparathyroidism, and Gs deficiency. In: Spiegel AM, ed. G Proteins, Receptors, and Disease. Totowa, NJ: Humana Press; 1998;23-56.
17. Farfel Z, Brothers VM, Brickman AS, Conte F, Neer R, Bourne HR. Pseudohypoparathyroidism: inheritance of deficient receptor-cyclase coupling activity. Proc Natl Acad Sci USA. 1981;78:3098-3102.
18. Aldred MA. Genetics of pseudohypoparathyroidism types Ia and Ic. J Pediatr Endocrinol Metab. 2006;19(suppl 2):635-640.
19. Mantovani G, Spada A. Mutations in theGsα gene causing hormone resistance. Best Pract Res Clin Endocrinol Metab. 2006;20:501-513.
20. Linglart A, Carel JC, Garabédian M, Lé T, Mallet E, Kottler ML. GNAS1 lesions in pseudohypoparathyroidism Ia and Ic: genotype phenotype relationship and evidence of the maternal transmission of the hormonal resistance. J Clin Endocrinol Metab. 2002;87:189-197.
21. Thiele S, de Sanctis L, Werner R, et al. Functional characterization of GNAS mutations found in patients with pseudohypoparathyroidism type Ic defines a new subgroup of pseudohypoparathyroidism affecting selectively Gsα-receptor interaction. Hum Mutat. 2011;32:653-660.
22. Wu WI, Schwindinger WF, Aparicio LF, Levine MA. Selective resistance to parathyroid hormone caused by a novel uncoupling mutation in the carboxyl terminus of Gα(s). A cause of pseudohypoparathyroidism type Ib. J Biol Chem. 2001;276:165-171.
23. de Nanclares GP, Fernández-Rebollo E, Santin I, et al. Epigenetic defects of GNAS in patients with pseudohypoparathyroidism and mild features of Albright's hereditary osteodystrophy. J Clin Endocrinol Metab. 2007;92:2370-2373.
24. Mariot V, Maupetit-Méhouas S, Sinding C, Kottler ML, Linglart A. A maternal epimutation of GNAS leads to Albright osteodystrophy and parathyroid hormone resistance. J Clin Endocrinol Metab. 2008;93:661-665.
25. Mantovani G, de Sanctis L, Barbieri AM, et al. Pseudohypoparathyroidism and GNAS epigenetic defects: clinical evaluation of Albright hereditary osteodystrophy and molecular analysis in 40 patients. J Clin Endocrinol Metab. 2010;95:651-658.
26. Sanchez J, Perera E, Jan de Beur S, et al. Madelung-like deformity in pseudohypoparathyroidism type 1b. J Clin Endocrinol Metab. 2011;96:E1507-E1511.
27. Unluturk U, Harmanci A, Babaoglu M, et al. Molecular diagnosis and clinical characterization of pseudohypoparathyroidism type-Ib in a patient with mild Albright's hereditary osteodystrophy-like features, epileptic seizures, and defective renal handling of uric acid. Am J Med Sci. 2008;336:84-90.
28. Izzi B, Decallonne B, Devriendt K, et al. A new approach to imprinting mutation detection in GNAS by Sequenom EpiTYPER system. Clin Chim Acta. 2010;411:2033-2039.
29. Maupetit-Méhouas S, Mariot V, Reynès C, et al. Quantification of the methylation at the GNAS locus identifies subtypes of sporadic pseudohypoparathyroidism type Ib. J Med Genet. 2011;48:55-63.
30. Mantovani G, Elli FM, Spada A. GNAS epigenetic defects and pseudohypoparathyroidism: time for a new classification? Horm Metab Res. 2012;44:716-723.
31. Zazo C, Thiele S, Martín C, et al. Gsα activity is reduced in erythrocyte membranes of patients with pseudohypoparathyroidism due to epigenetic alterations at theGNASlocus. J Bone Miner Res. 2011; 26:1864-1870.
32. Lee H, GrahamJMJr, Rimoin DL, et al.Exomesequencing identifies PDE4D mutations in acrodysostosis. Am J Hum Genet. 2012;90: 746-751.
33. Linglart A, Menguy C, Couvineau A, et al. Recurrent PRKAR1A mutation in acrodysostosis with hormone resistance.NEngl J Med. 2011;364:2218-2226.
34. Michot C, Le Goff C, Goldenberg A, et al. Exome sequencing identifies PDE4D mutations as another cause of acrodysostosis. Am J Hum Genet. 2012;90:740-745.
35. Klenke S, Siffert W, Frey UH. A novel aspect of GNAS imprinting: higher maternal expression of Gαs in human lymphoblasts, peripheral blood mononuclear cells, mammary adipose tissue, and heart. Mol Cell Endocrinol. 2011;341:63-70.
36. Court F, Martin-Trujillo A, Romanelli V, et al. Genome-wide allelic methylation analysis reveals disease-specific susceptibility to multiple methylation defects in imprinting syndromes.HumMutat. 2013; 34:595-602.
37. Maupetit-Méhouas S, Azzi S, Steunou V, et al. Simultaneous hyperand hypomethylation at imprinted loci in a subset of patients with GNAS epimutations underlies a complex and different mechanism of multilocus methylation defect in pseudohypoparathyroidism type 1b. Hum Mutat. 2013;34:1172-1180.
38. Perez-Nanclares G, Romanelli V, Mayo S, et al. Detection of hypomethylation syndromeamongpatients with epigenetic alterations at the GNAS locus. J Clin Endocrinol Metab. 2012;97:E1060-E1067.
39. Meyer E, Lim D, Pasha S, et al. Germline mutation in NLRP2 (NALP2) in a familial imprinting disorder (Beckwith-Wiedemann Syndrome). PLoS Genet. 2009;5:e1000423.
40. Mackay DJ, Callaway JL, Marks SM, et al. Hypomethylation of multiple imprinted loci in individuals with transient neonatal diabetes is associated with mutations in ZFP57. Nat Genet. 2008;40: 949-951.